Blood-Brain Barrier Penetration and CNS Distribution Achieving sufficient CNS concentrations is a critical pharmacokinetic requirement for a procognitive compound, and Dihexa's peptidomimetic design addresses this challenge
AC: adenylate cyclase ADP: adenosine diphosphate AMPK: adenosine monophosphate-activated protein kinase ATP: adenosine triphosphate BAT: brown adipose tissue BCAA: branched chain amino acids cAMP: cyclic adenosine monophosphate CR: caloric restriction GCG: glucagon GIP: glucose-dependent insulinotropic polypeptide GLP-1: glucagon-like peptide-1 GLP-1RAs: glucagon-like peptide-1 receptor agonists Gs: guanine nucleotide-binding protein GTT: glucose tolerance test HSL: hormone-sensitive lipase MAPK: mitogen-activated protein kinase NE: noradrenaline PGC1: peroxisome proliferator-activated receptor gamma coactivator-1 alpha PKA: protein kinase A PPAR: peroxisome proliferator-activated receptor SAT: subcutaneous adipose tissue SIRT1: silent information regulator type 1 T2DM: type 2 diabetes mellitus UCP1: uncoupling protein 1 VAT: visceral adipose tissue WAT: white adipose tissue NT: Conceptualization, Data curation, Investigation, Resources, Visualization, Writingoriginal draft, Writingreview & editing
If both wires are black, look for one of them to have white dashes on it that's the positive wire
Findings suggest caution in short-term use of WMMs without long-term behavioural and clinical support to maintain outcomes
P.DooseD
by the third month, it will increase GLP-1 levels
